Eton Pharmaceuticals Wins FDA Nod for DESMODA – Easier Treatment for Rare Thirst Disorder

FDA approves DESMODA, the first ready-to-use liquid medicine for central diabetes insipidus. It helps stop extreme thirst & frequent peeing with easier, safer precise dosing for kids & adults.

Eton Pharmaceuticals Wins FDA Nod for DESMODA – Easier Treatment for Rare Thirst Disorder
Credit: Sarah Silbiger/Getty Images
Already have an account? Sign in.